Explore the 2026 Scientific Program & Speaker Faculty

Explore our confirmed speakers, and scientific sessions shaping the next wave of targeted protein degradation and induced proximity therapeutics.

Download the full program to access:

  • 80+ leading speakers from Arvinas, Amgen, Nurix, Monte Rosa, Revolution Medicines and more
  • See a glimpse of the 350+ attendees across pharma, biotech & academia
  • 4 days of peer-led scientific sessions covering discovery to clinical development
63771

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Attending Companies Include

Biogen - 9th TPD & Induced Proximity Summit
bms logo
concarlo therapeutics - 9th TPD & Induced Proximity Summit
Load More

Snapshot of the 2026 Speaker Faculty:

Lynda Groocock

Director
Bristol Myers Squibb

Wolf Ruprecht Wiedemeyer

Senior Director, Discovery Biology
Revolution Medicines

Stuart Schreiber

Professor
Harvard Medical School

Arthur Sands

Chief Executive Officer
Nurix Therapeutics, Inc.

Randy Teel

President & Chief Executive Officer
Arvinas, Inc.

Paige Mahaney

Chief Scientific Officer
C4 Therapeutics Inc

Adrian Gottschalk

President & Chief Executive Officer
Foghorn Therapeutics

Phil Chamberlain

Co-Founder, President & Chief Executive Officer
Neomorph

Ryan Potts

Vice President, Research
Amgen Inc.

Debora Bonenfant

Vice President & Head of Proteomics
Monte Rosa Therapeutics
Request the Sample Attendee List
Register Now